Ali Behbahani Insider Trading $BDTX Black Diamond Therapeutics, Inc.
Get free email notifications about insider trading for Ali Behbahani.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ali Behbahani. Ali Behbahani is 10% Owner in Marker Therapeutics, Inc. ($MRKR) and Director in NEVRO CORP ($NVRO) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and Director in Nkarta, Inc. ($NKTX).
Ali Behbahani in Black Diamond Therapeutics, Inc.
Trading Symbol: BDTXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 547 shares
Latest Transaction: Mar 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ali Behbahani in Black Diamond Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, AKUS, BDTX, CRSP, GNCA, MRKR, MTCR, MIRM, NVRO, NKTX, OYST, RGLS, TRVI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2021 | BDTX | Black Diamond Ther ... | Behbahani Ali | Director | Grant | A | 24.01 | 547 | 13,133 | 547 | 0 to 547 |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Behbahani Ali | Director | Option Exercise | C | 0.00 | 1,422,862 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Behbahani Ali | Director | Option Exercise | C | 0.00 | 6,565,290 | 0 | 0 | |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Behbahani Ali | Director | Buy | P | 19.00 | 800,000 | 15,200,000 | 3,448,757 | 2.6 M to 3.4 M (+30.20 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Behbahani Ali | Director | Buy | C | 0.00 | 471,800 | 0 | 2,648,757 | 2.2 M to 2.6 M (+21.67 %) |
Feb 05 2020 | BDTX | Black Diamond Ther ... | Behbahani Ali | Director | Buy | C | 0.00 | 2,176,957 | 0 | 2,176,957 | 0 to 2.2 M |
Page: 1